Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.

The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?

• Coronavirus daily news updates, January 26: What to know today about COVID-19 in the Seattle area, Washington state and the world - The Seattle Times
  Wed, 26 Jan 2022 14:34 GMT
• Coronavirus Briefing: Europe’s Split Over Omicron - The New York Times
  Wed, 26 Jan 2022 23:03 GMT
• US coronavirus hospitalizations plateau nationwide after big Northeast drop - The Washington Post
  Wed, 26 Jan 2022 23:55 GMT
• Brazil reports record high 224567 cases of coronavirus - Reuters
  Wed, 26 Jan 2022 21:18 GMT
• Munich schools wheel out 7500 mobile UV-C units to combat coronavirus - LEDs Magazine
  Wed, 26 Jan 2022 19:02 GMT
• Coronavirus in Oregon: 8,207 cases, as state surpasses more than 6,000 deaths - OregonLive
  Thu, 27 Jan 2022 01:43 GMT
• The latest on the coronavirus pandemic and the Omicron variant - CNN
  Wed, 26 Jan 2022 17:43 GMT
• New coronavirus cases jump again in Florence | The Daily Independent at YourValley.net - Your Valley
  Wed, 26 Jan 2022 17:34 GMT
• Illinois Coronavirus Updates: Free Tests From Government Start Arriving, COVID Deaths Rising - NBC Chicago
  Wed, 26 Jan 2022 19:23 GMT
• As Europe begins to 'live with the coronavirus,' could the US follow? - CNN
  Wed, 26 Jan 2022 13:00 GMT
• Hawaii records 3 new coronavirus-related deaths, 2,050 additional infections - Honolulu Star-Advertiser
  Thu, 27 Jan 2022 01:41 GMT
• COVID-19: State update - 1,145,245 coronavirus cases, 15,523 deaths - KATC Lafayette News
  Wed, 26 Jan 2022 20:52 GMT
• Tuesday coronavirus update: Minnesota records 37 deaths, 35,504 infections - TwinCities.com-Pioneer Press
  Tue, 25 Jan 2022 18:10 GMT
• As new variants emerge, US government turns attention to a universal coronavirus vaccine - ABC News
  Wed, 26 Jan 2022 20:40 GMT
• Coronavirus: 2,592 new cases, 28 more deaths reported in Orange County on Jan. 26 - OCRegister
  Wed, 26 Jan 2022 20:17 GMT

• PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
  Mon, 20 Sep 2021 21:44:10 -0400
  COVID-19 -- Worldwide/Unknown
  A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
  The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
  The companies still must

• COVID-19 lockdown, personal protective equipment, hyper-hygiene and allergy Wed, 26 Jan 2022 06:00:00 -0500
  At the beginning of Sars-Cov 2 pandemic, in the absence of "targeted" therapies, the national health authorities have introduced some measures aimed at reducing the spread of infection in the community (lockdown, social distancing, personal protective equipment (PPE), personal hygiene and disinfection of living environments). All the containment measures have led to both positive and negative effects in patients with allergic diseases. We believe that further studies should be undertaken to...
• Covid-19: Contributions from Psychopharmacology Wed, 26 Jan 2022 06:00:00 -0500
  The COVID-19 pandemic is causing a major burden on personal health, healthcare systems and the global economy. For the last two years the COVID-19 pandemic has dramatically changed our lives in many personal and professional areas. For millions of us, due to infection rates, but also to protection measures such as lockdowns the corona pandemic has significantly changed the way we work, how we live, and how we interact with technology. In addition to the development of effective vaccines,...
• A novel machine learning scheme for face mask detection using pretrained convolutional neural network Wed, 26 Jan 2022 06:00:00 -0500
  Corona virus 2019 (COVID-19) erupted toward the end of 2019, and it has continued to be a source of concern for a large number of people and organizations well into 2020. Wearing a face cover has been shown in studies to reduce the risk of viral transmission while also providing a sense of security. Be that as it may, it isn't attainable to physically follow the execution of this strategy. This proposed system is built by pretrained deep learning model, Vgg16. The proposed scheme is easy to...
• Could Guillain-Barré syndrome be triggered by COVID-19 vaccination? Wed, 26 Jan 2022 06:00:00 -0500
  Due to SARS-COV-2 (COVID-19) pandemic and its catastrophic impact on society, the FDA granted emergency use authorization for some vaccines. Possible rare side effects could not have been observed in this relatively short period. We are reporting an elderly lady with multiple comorbidities who presented with progressive lower limb weakness that started seven days after receiving the first dose of the COVID-19 vaccine. The electrodiagnostic study showed demyelinating polyneuropathy with secondary...
• Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study Wed, 26 Jan 2022 06:00:00 -0500
  CONCLUSION: Regardless of prior therapy and disease refractory status, selinexor treatment demonstrated results consistent with its novel mechanism of action and lack of cross-resistance. Thus, single agent oral selinexor can induce deep, durable, and tolerable responses in patients with DLBCL who have recurrent disease after several chemoimmunotherapy combination regimens.
• Radiological Assistance In Managing Workflow In Medical And Surgical Indications At Shifa International Hospital In COVID-19 Pandemic Tue, 25 Jan 2022 06:00:00 -0500
  CONCLUSION: The radiology department plays a central role in streamlining the patient inflow admitted for surgical or medical indications and thus needs to be prepared for patient surges and increased volumes, with large influxes of patients to the emergency department that will require diagnostic imaging and interventional services.
• Nanoparticle protein corona evolution: from biological impact to biomarker discovery Tue, 25 Jan 2022 06:00:00 -0500
  Nanoparticles exposed to biological fluids such as blood, quickly interact with their surrounding milieu resulting in a biological coating that results in large part as a function of the physicochemical properties of the nanomaterial. The large nanoparticle surface area-to-volume ratio further augments binding of biological molecules and the resulting biomolecular or protein corona, once thought of as problematic biofouling, is now viewed as a rich source of biological information that can guide...
• Recovery of Supraspinal Microstructural Integrity and Connectivity in Patients Undergoing Surgery for Degenerative Cervical Myelopathy Tue, 25 Jan 2022 06:00:00 -0500
  CONCLUSION: Recovery of microstructural integrity along the corticospinal tract and other sensorimotor pathways, together with supraspinal reorganization of microstructural connectivity within sensory and motor-related regions, was associated with neurological improvement after surgical decompression.
• Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) : Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR) Tue, 25 Jan 2022 06:00:00 -0500
  CONCLUSION: These Guidelines are based on two principal aspects: they are couple-oriented and place high value in assessing, preventing, and treating risk factors for infertility. These Guidelines also highlighted that male infertility and in particular testicular function might be a mirror of general health of a man.
• Teilnahme am Regelunterricht (Präsenzunterricht) in der Schule ohne Mund-Nasen-Bedeckung: GG Art. 2 Abs. 1 u. 2, 19 Abs. 4; VwGO 80 Abs. 5,123 Abs. 1 S. 2; ZPO 920 Abs. 2 ZPO, 294; IfSG 32 S. 1 u. 2, 28a Abs. 1 S. 1; Nds. Corona-Verordnung 3 Abs. 6, 13 Abs. 1 S. 4ff.; NSchG 31 Abs. 1, Abs. 10 Nr. 1 lit. h) Tue, 25 Jan 2022 06:00:00 -0500
  No abstract